“‘Psychedelics’ Tag”,2019-12-14 (anxiety, depression, illusion-of-depth bias)⁠:

Bibliography for tag psychedelic, most recent first: 3 related tags, 156 annotations, & 79 links (parent).

• See Also
• Gwern
  • “Why Dreams Don’t Matter”, Gwern2021
  • “Spaced Repetition for Efficient Learning”, Gwern2009
  • “The Algernon Argument”, Gwern2010
• Links
  • “Hypercomputation without Bothering the Cactus People: Software Development for the DMT Headspace”, Flipper2024
  • “AlphaFold2 Structures Template Ligand Discovery”, Lyu et al 2023
  • “Elon Musk’s Shadow Rule: How the US Government Came to Rely on the Tech Billionaire—And Is Now Struggling to Rein Him in § Biography”, Farrow2023
  • In Vivo Biosynthesis of N,N-Dimethyltryptamine, 5-MeO-N,N-Dimethyltryptamine, and Bufotenine in E. Coli, Friedberg et al 2023
  • “Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley”, Grind & Bindley2023
  • “Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients”, Lii et al 2023
  • “Are Woo Non-Responders Defective?”, Alexander2023
  • “Ketamine versus ECT for Non-Psychotic Treatment-Resistant Major Depression”, Anand et al 2023
  • “The Evolution and Ecology of Psilocybin in Nature”, Meyer & Slot2023c
  • “Effect of Psilocybin on Marble Burying in ICR Mice: Role of 5-HT1A Receptors and Implications for the Treatment of Obsessive-Compulsive Disorder”, Singh et al 2023
  • Homo Medicus: The Transition to Meat Eating Increased Pathogen Pressure and the Use of Pharmacological Plants in Homo, Hagen et al 2023
  • “Pharmacological Mechanism of the Non-Hallucinogenic 5-HT2A Agonist Ariadne and Analogs”, Cunningham et al 2023
  • “Single-Dose Psilocybin-Assisted Therapy in Major Depressive Disorder: A Placebo-Controlled, Double-Blind, Randomized Clinical Trial”, Rotz et al 2022
  • “A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability”, Barber et al 2022
  • “Acid Liberalism: Silicon Valley’s Enlightened Technocrats, and the Legalization of Psychedelics”, Tvorun-Dunn2022
  • “Adverse Effects of Ayahuasca: Results from the Global Ayahuasca Survey”, Bouso et al 2022
  • “5-MeO-DMT Modifies Innate Behaviors and Promotes Structural Neural Plasticity in Mice”, Jefferson et al 2022
  • “Low Doses of Lysergic Acid Diethylamide (LSD) Increase Reward-Related Brain Activity”, Glazer et al 2022
  • “Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial”, Bogenschutz et al 2022
  • “Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica”, Orozco & Harris2022
  • “Increased Global Integration in the Brain After Psilocybin Therapy for Depression”, Daws et al 2022
  • “Trips and Neurotransmitters: Discovering Principled Patterns across 6,850 Hallucinogenic Experiences”, Ballentine et al 2022
  • “The Insights Psychedelics Give You Aren’t Always True: The Study of False—Sober—Insights Teaches Us to Be Wary of Accepting Every Realization from Psychedelic Trips without Critical Thinking”, Love2022
  • “Efficacy and Safety of Psilocybin-Assisted Treatment for Major Depressive Disorder: Prospective 12-Month Follow-Up”, Gukasyan et al 2022
  • “Digital Localization in an Illicit Market Space: Interactional Creation of a Psychedelic Assemblage in a Darknet Community of Exchange”, Sawicka et al 2022
  • “Evenings With Molly: Adult Couples’ Use of MDMA for Relationship Enhancement”, Colbert & Hughes2022
  • “The Effects of Psilocybin on Cognitive and Emotional Functions in Healthy Participants: Results from a Phase 1, Randomized, Placebo-Controlled Trial Involving Simultaneous Psilocybin Administration and Preparation”, Rucker et al 2022
  • “United States National Institutes of Health Grant Funding for Psychedelic-Assisted Therapy Clinical Trials from 2006^–₁₄2020”, Barnett et al 2022
  • “Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review”, Strous et al 2022
  • “Debunking the Myth of ‘Blue Mondays’: No Evidence of Affect Drop After Taking Clinical MDMA”, Sessa et al 2021
  • “Microevidence for Microdosing With Psilocybin Mushrooms: a Double-Blind Placebo-Controlled Study of Subjective Effects, Behavior, Creativity, Perception, Cognition, and Brain Activity”, Cavanna et al 2021
  • “Psychedelics Alter Metaphysical Beliefs”, Timmermann et al 2021
  • “Adults Who Microdose Psychedelics Report Health Related Motivations and Lower Levels of Anxiety and Depression Compared to Non-Microdosers”, Rootman et al 2021
  • “Largest Psilocybin Trial Finds the Psychedelic Is Effective in Treating Serious Depression”, Goldhill2021
  • “Psilocybin Therapy Increases Cognitive and Neural Flexibility in Patients With Major Depressive Disorder”, Doss et al 2021
  • “Wastewater Analysis for Psychoactive Substances at Music Festivals across New South Wales, Australia in 2019–2020”, Jonathan et al 2021
  • “Psilocybin Induces Rapid and Persistent Growth of Dendritic Spines in Frontal Cortex in Vivo”, Shao et al 2021
  • “Leroy’s Elusive Little People: A Systematic Review on Lilliputian Hallucinations”, Blom2021
  • “What Happens When You Ask Questions to the DMT Entities?”, Josikinz & algekalipso 2021
  • “Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor”, Dong et al 2021
  • “MDMA-Assisted Therapy for Severe PTSD: a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study”, Mitchell et al 2021
  • “A ’Trip’ to the Intensive Care Unit: An Intravenous Injection of Psilocybin”, Giancola et al 2021
  • “The Psychology of Philosophy: Associating Philosophical Views With Psychological Traits in Professional Philosophers”, Yaden & Anderson2021
  • “Trial of Psilocybin versus Escitalopram for Depression”, Carhart-Harris et al 2021
  • “Self-Blinding Citizen Science to Explore Psychedelic Microdosing”, Szigeti et al 2021
  • “Citizen Science: Asking Questions of Psychedelic Microdosing”, Cameron2021
  • “The Acute Antisuicidal Effects of Single-Dose Intravenous Ketamine and Intranasal Esketamine in Individuals With Major Depression and Bipolar Disorders: A Systematic Review and Meta-Analysis”, Xiong et al 2021
  • “Positive Expectations Predict Improved Mental-Health Outcomes Linked to Psychedelic Microdosing”, Kaertner et al 2021
  • “Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial”, Davis et al 2021
  • “A Non-Hallucinogenic Psychedelic Analogue With Therapeutic Potential”, Cameron et al 2021
  • “Psychedelic Drugs: Neurobiology and Potential for Treatment of Psychiatric Disorders”, Vollenweider & Preller2020
  • “Obscure and Unknown: Deliriants of the Edgewood Arsenal Human Experiments”, space_crustacean 2020
  • “Survey of Entity Encounter Experiences Occasioned by Inhaled N,N-Dimethyltryptamine: Phenomenology, Interpretation, and Enduring Effects”, Davis et al 2020
  • “Psychedelic Psychiatry’s Brave New World”, Nutt et al 2020
  • “Long-Term Follow-Up of Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients With Life-Threatening Cancer”, Agin-Liebes et al 2020
  • “What Intellectual Progress Did I Make In The 2010s?”, Alexander2020
  • “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers”, Family et al 2020
  • “Metabolic Engineering of Saccharomyces Cerevisiae for the de Novo Production of Psilocybin and Related Tryptamine Derivatives”, Milne et al 2020
  • “Logarithmic Scales of Pleasure and Pain: Rating, Ranking, and Comparing Peak Experiences Suggest the Existence of Long Tails for Bliss and Suffering”, Computing2019
  • “Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers”, Bershad et al 2019
  • “A Systematic Study of Microdosing Psychedelics”, Polito & Stevenson2018
  • “Exploring the Effect of Microdosing Psychedelics on Creativity in an Open-Label Natural Setting”, Prochazkova et al 2018
  • “Discovery of Psychoactive Plant and Mushroom Alkaloids in Behavior-Modifying Fungal Cicada Pathogens”, Boyce et al 2018
  • “Convergent Evolution of Psilocybin Biosynthesis by Psychedelic Mushrooms”, Awan et al 2018
  • “Psychedelics and the Essential Importance of Context”, Carhart-Harris et al 2018
  • “Psilocybin With Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up”, Carhart-Harris et al 2018
  • “Serotonin and Brain Function: a Tale of Two Receptors”, Carhart-Harris & Nutt2017
  • “The Challenging Experience Questionnaire: Characterization of Challenging Experiences With Psilocybin Mushrooms”
  • “Survey Study of Challenging Experiences After Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences”
  • “NMDAR Inhibition-Independent Antidepressant Actions of Ketamine Metabolites”, Zanos et al 2016
  • “Rapid and Sustained Symptom Reduction following Psilocybin Treatment for Anxiety and Depression in Patients With Life-Threatening Cancer: a Randomized Controlled Trial”, Ross et al 2016
  • “Hunting and Hallucinogens: The Use of Psychoactive and Other Plants to Improve the Hunting Ability of Dogs”, Bennett & Alarcón2015
  • “Clusters of Individual Experiences Form a Continuum of Persistent Non-Symbolic Experiences [PNSE] in Adults”, Martin2013
  • “A Philosopher Defends Religion [Review of Plantinga, Where the Conflict Really Lies]”, Nagel2012
  • “A Parasite from Outer Space: How Sergei Kurekhin Proved That Lenin Was a Mushroom”, Yurchak2011
  • “Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness”, MacLean et al 2011
  • “Hyper-Priming in Cannabis Users: A Naturalistic Study of the Effects of Cannabis on Semantic Memory Function”, Morgan et al 2010
  • “A Methodology for Studying Various Interpretations of the N,N-Dimethyltryptamine-Induced Alternate Reality”, Rodriguez2006
  • “The Bayesian Brain: the Role of Uncertainty in Neural Coding and Computation”, Knill & Pouget2004
  • Ketamine: Dreams and Realities, Jansen2004
  • “Kary B. Mullis’s Nobel Lecture”, Mullis1993
  • “A Multidisciplinary Approach to Ritual Enema Scenes on Ancient Maya Pottery”, Smet & Hellmuth1986
  • “Religious Behavior in Animals and Man: Drug-Induced Effects”, Siegel1977
  • “An Ethologic Search for Self-Administration of Hallucinogens”, Siegel1973
  • An Essay On The Psychology Of Invention In The Mathematical Field, Hadamard1945
  • “Entheogens in Buddhism”
  • “The DMT ‘Elves’ People Meet While Tripping”
  • “Datura (also Jimson Weed; Thorn Apple)”
  • “Nutmeg (also Myristica Fragrans)”
  • “Insane Brain Train: Massive Dosing—The LSD Thumbprint”
  • “10 Months of Acid”
  • “Psychedelic Pioneer and Confidence Man”
  • “Psychedelics in American Religious Experience”
  • “I Ran an Ultramarathon Tripping Balls on LSD”
  • “Psychedelic Psilocybin Therapy for Depression Granted Breakthrough Therapy Status by FDA”
  • “Travels in the New Psychedelic Bazaar”
  • “Travels in the New Psychedelic Bazaar”
  • “Volumetric Liquid Dosing”, Wiki2024
  • “Brilliant Visions: Peyote among the Aesthetes”
  • “Fungi, Folklore, and Fairyland”
  • “State-Space of Drug Effects: Results”
  • “LSD and Quantum Measurements: Can You See Schrödinger’s Cat Both Dead and Alive on Acid?”
  • “Psychedelic Turk: A Platform for People on Altered States of Consciousness”
  • “Treating Cluster Headaches Using N,N-DMT and Other Tryptamines”
  • “Break Out of the Simulation Day: Televised Entity Contact, Injection Pulling Experiments, and the Brain As a Game Engine”
  • “Making Amazing Recreational Drug Cocktails”
  • “Qualia Research Institute: The Musical Album of 2024 (v1)”
  • “Compass Pathways Is Threatening to Create a Magic Mushroom Monopoly”
  • “Psilocybin Drug Trials: Psychedelics (acid, LSD, Magic Mushrooms) Not Only Make Us More Spiritual and Religious”
  • “Benefits Of Microdosing With LSD And Psilocybin Mushrooms”
  • “Why Were Early Psychedelicists So Weird?”
  • “Book Review: PiHKaL”
  • “SSC Journal Club: Serotonin Receptors”
  • “Book Review: The Electric Kool-Aid Acid Test”
  • “SSC Journal Club: Relaxed Beliefs Under Psychedelics And The Anarchic Brain”
  • “Does Psilocybin Cause Changes in Personality? Maybe, but Not so Fast”
  • “Massive Lykos and MAPS Layoffs amid FDA Rejection Reactions; 3 MDMA Papers Retracted; and False Insights”
  • “Learn What Effects Low Dosage of Psychedelic Have on Your Mental Health”
  • Drugs 2.0
  • “A Look Down Track B”
  • “On Nutt/Carhart-Harris On Serotonin”
  • “The Early, State-Sanctioned LSD Experiments in Communist Bulgaria”
  • “Atai: Biotech Company Funding Research on Psilocybin, Other Drugs for Depression”
  • “Rapid Antidepressant Effects of the Psychedelic Ayahuasca in Treatment-Resistant Depression: a Randomized Placebo-Controlled Trial”
  • “Magic Mushrooms Were the Inspiration for Frank Herbert’s Science Fiction Epic Dune”
  • “The Amazing Psychedelic Bamboozle”
  • “Erowid Ketamine Vault”
  • “LSD Purity”
  • “Abstracts regarding Low Doses of LSD (Less Than 50μg)”
  • “Ketamine”
  • “Xenon Trip Reports”, Erowid2024
  • “What Ketamine Therapy Is Like”
  • “Ketamine Therapy Is Going Mainstream. Are We Ready?”
  • “The Trip Treatment”
  • “A Field Guide to Psychedelics”
  • “Hallucinogens Have Doctors Tuning In Again”
  • “How Psychedelic Drugs Can Help Patients Face Death”
  • “Molly at the Marriott: Inside America’s Premier Psychedelics Conference”
  • “Nicholas Sand, Chemist Who Sought to Bring LSD to the World, Dies at 75”
  • “Johns Hopkins Opens New Center for Psychedelic Research”
  • “Tim Ferriss, the Man Who Put His Money Behind Psychedelic Medicine”
  • “The Colossal Government Failure That Obstructed a Potentially Major Medical Breakthrough”
  • “Increased Amygdala Responses to Emotional Faces After Psilocybin for Treatment-Resistant Depression”
  • “The Life-Changing Magic of Mushrooms: A Single Dose of Magic Mushrooms Can Make People With Severe Anxiety and Depression Better for Months, according to a Landmark Pair of New Studies.”
  • “Do Drugs Make Religious Experience Possible? They Did for James and for Other Philosopher-Mystics of His Day. James’s Experiments With Psychoactive Drugs Raise Difficult Questions about Belief and Its Conditions”
  • “Michael Pollan on What It’s Like to Trip on Mushrooms”
  • “Massospora, the Parasite That Drugs Cicadas”
  • “Study Finds Mushrooms Are the Safest Recreational Drug”
  • “Psychedelics Weren’t As Common in Ancient Cultures As We Think”
  • “I Took a Lot of Drugs at a Psychedelic Boot Camp”
  • “How One Man Tried to Build a DMT-Based Cult on Reddit and Lost Everything”
  • “The Magic Jews”
  • “Scientists Want You to Give Them Money to Study Psychedelics”
  • “Hackers, Mason Jars, and the Psychedelic Science of DIY Shrooms”
  • “The High-Stakes Race to Engineer New Psychedelic Drugs”
  • “This Is My Brain on Salvia”
  • Sort By Magic
    • psychoactive-therapy psychedelic-discovery neuroplasticity-approaches hallucinogen-research mystical-experiences
    • psilocybin-recovery
    • psychotherapy-insights psilocybin-effect metaphysical-shift alcohol-recovery depression-therapy
    • psilocybin-therapy psilocybin-research depression-treatment anxiety-relief cancer-care long-term-outcomes psilocybin-therapy
    • microdosing-psychotropics
  • Wikipedia
• Miscellaneous
• Bibliography